Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | DRD4 | P21917 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23706763 | 0.87 | ALDH1A1 (0.44) | KMT2AMEN1DRD4ALDH1A1KDM4E | |
| SCHEMBL23706762 | 0.84 | ALDH1A1 (0.48) | KMT2AMEN1DRD4ALDH1A1KDM4E | |
| SCHEMBL21776353 | 0.83 | KMT2A (0.45) | KMT2AMEN1DRD4ALDH1A1KDM4E | |
| SCHEMBL13013046 | 0.82 | KMT2A (0.64) | KMT2AMEN1ALDH1A1KDM4EUSP2 | |
| SCHEMBL3969316 | 0.81 | KDM4E (0.50) | KMT2AMEN1ALDH1A1KDM4EUSP2 | |
| SCHEMBL9621208 | 0.81 | KDM4E (0.50) | KMT2AMEN1ALDH1A1KDM4EUSP2 | |
| SCHEMBL23155703 | 0.81 | KMT2A (0.46) | KMT2AMEN1DRD4ALDH1A1KDM4E | |
| SCHEMBL23155599 | 0.81 | KMT2A (0.46) | KMT2AMEN1DRD4ALDH1A1KDM4E | |
| SCHEMBL23706754 | 0.80 | MAPT (0.55) | KMT2AMEN1DRD4KDM4EUSP2 | |
| SCHEMBL23706767 | 0.79 | DRD4 (0.41) | DRD4SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250262589-A1 | AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE | TOSOH CORPORATION (JP) | 2025-08-21 | — | — | US | disclosed |
| WO-2025062883-A1 | SYSTEM FOR REMOVING NITROGEN OXIDES AND/OR SULFUR OXIDES, METHOD FOR REMOVING NITROGEN OXIDES AND/OR SULFUR OXIDES, SYSTEM FOR SEPARATING AND CAPTURING CARBON DIOXIDE, AND METHOD FOR SEPARATING AND CAPTURING CARBON DIOXIDE | 国立大学法人京都工芸繊維大学 | 2025-03-27 | — | — | WO | disclosed |
| EP-4494740-A1 | AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE | TOSOH CORPORATION (JP) | 2025-01-22 | — | — | EP | disclosed |
| CN-119095662-A | Amine composition for separating carbon dioxide | 东曹株式会社 | 2024-12-06 | — | — | CN | disclosed |
| US-20230356182-A1 | COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE | TOSOH CORPORATION (JP) | 2023-11-09 | — | — | US | disclosed |
| WO-2023204222-A1 | AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE | 東ソー株式会社 | 2023-10-26 | — | — | WO | disclosed |
| EP-4098348-A1 | COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE | Tosoh Corporation (JP) | 2022-12-07 | — | — | EP | disclosed |
| CN-114901383-A | Composition for separating carbon dioxide and method for separating carbon dioxide | 东曹株式会社 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021153650-A1 | COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE | 東ソー株式会社 | 2021-08-05 | — | — | WO | disclosed |
| US-10221191-B2 | Compounds for the treatment of cancer and inflammatory disease | SHY Therapeutics LLC | 2019-03-05 | — | — | US | disclosed |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221191-B2 | Compounds for the treatment of cancer and inflammatory disease | MAPK6, MAP3K6, MAPK4 | KMT2A 3544/4885MEN1 4080/4885DRD4 4871/4885 |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | KMT2A 3544/4885MEN1 4080/4885DRD4 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.